IP Library › Assignment 036827/0897
Patent Assignment
Reel/Frame 036827/0897

Assignment of Assignor's Interest

Recorded: 2015-10-09 Pages: 18
Assignors
TRIMEL BIOPHARMA SRL
Executed: 2015-10-08
TRIMEL PHARMACEUTICALS CORP.
Executed: 2015-10-08
Assignee
ACERUS PHARMACEUTICALS SRL
SUITE B, DURANTS BUSINESS CENTER, DURANTS, CHRIST CHURCH, BB17097, BARBADOS
Covered Properties (45)
Intranasal Methods of Treating Women for Anorgasmia with 0.6% and 0.72% Testosterone Gels
Patent: 9,757,388 →
Application: 13/471,445 →
Publication: US 2013/0059827
Intranasal 0.45% and 0.48% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 13/471,449 →
Publication: US 2013/0040922
Intranasal 0.15% and 0.24% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 13/471,450 →
Publication: US 2013/0045958
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 13/471,452 →
Publication: US 2013/0040923
Controlled Release Topical Testosterone Formulations and Methods
Application: 14/080,695 →
Methods of Treating Hypogonadism with Intranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application: 14/215,882 →
Female Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 14/442,919 →
Controlled Release Topical Testosterone Formulations and Methods
Application: 14/442,949 →
Publication: US 2015/0297733
Controlled Release Topical Testosterone Formulations and Methods
Application: 14/508,904 →
Methods of Treating Hypogonadism with Intranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application: 14/536,130 →
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 14/641,322 →
Intranasal 0.45% and 0.48% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 14/644,387 →
Intranasal 0.15% and 0.24% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 14/644,414 →
Male Testosterone Titration Methods, Male Intranasal Testosterone Bio-Adhesive Gel Formulations and Use Thereof for Treating Hypogonadism and Trt
Application: 14/646,571 →
Publication: US 2015/0290217
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application: 14/646,889 →
Controlled Release Topical Testosterone Formulations and Methods
Application: 14/713,706 →
Publication: US 2016/0113946
Intranasal 0.6% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/486,251 →
Intranasal 0.45% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/486,252 →
Intranasal 0.15% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/486,254 →
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/486,266 →
Intranasal 0.45% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/513,495 →
Intranasal 0.6% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/513,497 →
Intranasal 0.15% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/513,499 →
Intranasal 0.15% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application: 61/518,903 →
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application: 61/518,913 →
Intranasal 0.45% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application: 61/518,916 →
Intranasal 0.6% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
Application: 61/518,921 →
Intranasal 0.6% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/598,329 →
Intranasal 0.45% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/598,333 →
Intranasal 0.15% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/598,335 →
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/598,336 →
Controlled Release Topical Testosterone Formulations and Methods
Application: 61/726,564 →
Female Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/726,570 →
Female Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/727,112 →
Male Testosterone Titration Methods, Male Intranasal Testosterone Bio-Adhesive Gel Formulations and Use Thereof for Treating Hypogonadism and Trt
Application: 61/729,138 →
Controlled Release Topical Testosterone Formulations and Methods
Application: 61/729,304 →
Female Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 61/729,324 →
Male Testosterone Titration Methods, Male Intranasal Testosterone Bio-Adhesive Gel Formulations and Use Thereof for Treating Hypogonadism and Trt
Application: 61/729,406 →
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application: 61/802,297 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application: 61/802,354 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application: 61/802,388 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application: 61/802,724 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application: 61/802,727 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application: 61/802,737 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application: 61/802,739 →
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0121 →
Assignment of Assignor's Interest Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0843 →
Assignment of Assignor's Interest Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0574 →
Assignment of Assignor's Interest Sep 16, 2011
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER
To: TRIMEL BIOPHARMA, INC.
Reel/Frame 026917/0386 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028558/0907 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028558/0265 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028559/0674 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028559/0484 →
Security Agreement Jul 23, 2012
From: TRIMEL BIOPHARMA SRL
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028613/0855 →
Release of Security Interest Jul 25, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: TRIMEL BIOPHARMA SRL
Reel/Frame 033417/0304 →
Security Interest Jul 25, 2014
From: TRIMEL BIOPHARMA SRL
To: MIDCAP FUNDING V, LLC
Reel/Frame 033416/0897 →
Change of Name Dec 5, 2017
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 044693/0936 →
Security Interest Jan 24, 2018
From: ACERUS BIOPHARMA INC.
To: QUANTIUS INC.
Reel/Frame 044719/0767 →
Release of Security Interest Oct 9, 2018
From: MIDCAP FUNDING V TRUST
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 047207/0254 →
Intellectual Property Security Agreement Oct 11, 2018
From: ACERUS PHARMACEUTICALS CORPORATION; ACERUS BIOPHARMA INC.; ACERUS LABS INC.
To: SWK FUNDING LLC
Reel/Frame 047217/0760 →
Release of Security Interest Nov 2, 2018
From: QUANTIUS INC.
To: ACERUS PHARMACEUTICALS CORPORATION; ACERUS LABS INC.; ACERUS BIOPHARMA INC.
Reel/Frame 047399/0698 →
Assignment of Assignor's Interest Dec 19, 2019
From: TRIMEL BIOPHARMA SRL
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 051337/0832 →
Gudaitis Declaration Supporting Chain of Title May 13, 2021
From: TRIMEL BIOPHARMA INC.
To: ACERUS BIOPHARMA INC.
Reel/Frame 056252/0740 →
Assignment of Assignor's Interest May 13, 2021
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 056233/0589 →
Change of Name May 13, 2021
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 056238/0484 →
Employment Agreement May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056285/0129 →
Employment Agreement May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056284/0111 →
Employment Agreement May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056283/0289 →